Revvity Inc (STU:PKN)
€ 114.55 0.5 (0.44%) Market Cap: 14.29 Bil Enterprise Value: 16.21 Bil PE Ratio: 61.12 PB Ratio: 1.96 GF Score: 78/100

PerkinElmer Inc at Cowen Health Care Conference (Virtual) Transcript

Mar 07, 2022 / 03:30PM GMT
Release Date Price: €158.9 (+0.16%)
Max Masucci
Cowen and Company, LLC, Research Division - Senior Analyst

Good morning. Welcome to the 42nd Annual Cowen Healthcare Conference. I'm Max Masucci, one of our three life science and diagnostic tools analyst here at Cowen.

We're excited to have PerkinElmer at the conference again this year. And from Perkin, we have Jamey Mock, CFO. So thanks, Jamey, for spending some time here with us today.

James M. Mock
PerkinElmer, Inc. - Senior VP & CFO

Thanks for having us, Max. Good to see you.

Questions & Answers

Max Masucci
Cowen and Company, LLC, Research Division - Senior Analyst

Yes, absolutely. All right. Let's start with a question that is pretty standard across the board for most of our chats. The past fiscal year around 44% of revenues came from America, 31% from Europe, 25% from Asia, 19% of last year's revenues were generated from your diagnostics business in Europe. So just given the dynamics in Ukraine, Eastern Europe, it's worth checking in on your exposure from a customer type

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot